Overview

• Benchmarks fell nearly 1% for a sixth straight session, with the Sensex at 80,426.46 and the Nifty at 24,654.70.
• Pharma stocks dropped after President Trump set a 100% tariff on branded and patented drug imports from October 1, with an exemption for firms “building” US plants defined as breaking ground or under construction; Wockhardt fell about 9.4%.
• IT shares extended losses on higher H‑1B visa fees and Accenture’s weaker outlook, adding to pressure on export-heavy counters.
• Investor wealth eroded by roughly ₹15.2 lakh crore over six sessions, including about ₹4.51 lakh crore on Friday.
• FPIs sold around ₹15,293 crore over the period as DIIs bought about ₹19,517 crore, while BSE Midcap and Smallcap indices slid 1.96% and 2.05% on Friday.